Tg Therapeutics Inc (TGTX)

R&D to Revenue

26.00%

Fiscal year · Period ending:

TGTX logo

TGTX R&D to Revenue

Latest reported26.00%
TGTX FY R&D/Revenue (1100.00% → 26.00%)
High-resolution chart · PNG

TGTX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
25.9968%
28.6595%
32.6078%
4,500.9695%
3,327.5377%
109,142.1053%
101,434.2105%
101,179.6053%
63,581.5056%
43,633.9307%
28,511.3085%
20,576.5686%
8,282.6343%
108,001.7955%
0%
0%
0%
0%
0%
0%
0%
0%
0%
107.9504%
32.697%
21.0927%
91.6667%
100%
2,600%
1,100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.